Targeted pill trial aims to slow Parkinson's progression
Disease control
Recruiting now
This study is testing an oral medication called NEU-411 for people with early Parkinson's disease who have a specific genetic profile linked to the disease. About 150 participants will take either the drug or a placebo for one year to see if it can slow the progression of Parkins…
Phase: PHASE2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC